OBJECTIVE: The purpose of this study was to compare patient-reported outcomes after combined surgery for pelvic organ prolapse (POP) and stress urinary incontinence (SUI) between older and younger women. STUDY DESIGN: This was a retrospective cohort study including 122 younger (<65 years) and 70 older women (>/=65 years old) who underwent combined POP and SUI surgery. SUI and POP treatment failure were based on validated measures. Logistic regression was used to calculate adjusted odds ratios and 95% confidence interval [CI]. RESULTS: Mean follow-up was 10 +/- 1.2 months. Women in both age groups reported significant improvement in symptoms and life impact postoperatively. In multivariable analyses, older women had an increased odds of SUI treatment failure (adjusted odds ratio [AOR], 1.10; 95% CI, 1.05-2.5), but not POP treatment failure (AOR, 0.90; 95% CI, 0.29-2.8). CONCLUSION: Women 65 years and older undergoing combined surgery for POP and SUI are at risk for recurrent SUI, but still experience significant improvements in symptoms and life impact.
OBJECTIVE: The purpose of this study was to compare patient-reported outcomes after combined surgery for pelvic organ prolapse (POP) and stress urinary incontinence (SUI) between older and younger women. STUDY DESIGN: This was a retrospective cohort study including 122 younger (<65 years) and 70 older women (>/=65 years old) who underwent combined POP and SUI surgery. SUI and POP treatment failure were based on validated measures. Logistic regression was used to calculate adjusted odds ratios and 95% confidence interval [CI]. RESULTS: Mean follow-up was 10 +/- 1.2 months. Women in both age groups reported significant improvement in symptoms and life impact postoperatively. In multivariable analyses, older women had an increased odds of SUI treatment failure (adjusted odds ratio [AOR], 1.10; 95% CI, 1.05-2.5), but not POP treatment failure (AOR, 0.90; 95% CI, 0.29-2.8). CONCLUSION:Women 65 years and older undergoing combined surgery for POP and SUI are at risk for recurrent SUI, but still experience significant improvements in symptoms and life impact.
Authors: R C Bump; A Mattiasson; K Bø; L P Brubaker; J O DeLancey; P Klarskov; B L Shull; A R Smith Journal: Am J Obstet Gynecol Date: 1996-07 Impact factor: 8.661
Authors: Matthew D Barber; Steven Kleeman; Mickey M Karram; Marie Fidela R Paraiso; Mark Ellerkmann; Sandip Vasavada; Mark D Walters Journal: Am J Obstet Gynecol Date: 2008-12 Impact factor: 8.661
Authors: S L Tennstedt; H J Litman; P Zimmern; C Ghetti; J W Kusek; C W Nager; E R Mueller; S R Kraus; E Varner Journal: Int Urogynecol J Pelvic Floor Dysfunct Date: 2008-08-06